Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Markets and Drug Tourism

与毒品市场和毒品旅游相关的丙型肝炎病毒、艾滋病毒和药物过量的民族流行病学

• 批准号: 10409999
• 负责人: STEFFANIE A. STRATHDEE
• 金额: $ 56.18万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-01 至 2023-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10409999
• 关键词: Age; Antibodies; Behavior; Behavior Therapy; Behavioral; COVID test; COVID testing; COVID-19; COVID-19 health disparity; COVID-19 test; COVID-19 testing; COVID-19 vaccination; COVID-19 vaccine; COVID-19 vaccine evaluation; California; Caring; Communities; Coronavirus; Country; County; Criminal Justice; Data; Data Linkages; Databases; Electronic Health Record; Epidemiology; Ethnic Origin; Funding; Future; Geographic state; HIV; HIV/HCV; Health; Health Insurance; Healthcare Systems; Hepatitis B Vaccination; Hepatitis C virus; Homelessness; Human immunodeficiency virus test; Incidence; Infection; Infrastructure; Injecting drug user; Intervention; Interview; Legal; Measures; Medical; Mexico; Misinformation; National Institute of Drug Abuse; Natural experiment; Needle-Exchange Programs; Outcome; Overdose; Parents; Participant; Patient Self-Report; Pattern; Pharmaceutical Preparations; Population; Positioning Attribute; Prevalence; Prevention; Professional counselor; Proteins; Race; Randomized; Reporting; Research; Role; SARS-CoV-2 antibody; SARS-CoV-2 antigen; SARS-CoV-2 infection; Serology; Serology test; Services; Site; Structure; Subgroup; Surveys; Testing; Training; Transportation; Travel; Vaccinated; Vaccination; Vaccines; Visit; acceptability and feasibility; addiction; antigen test; base; brief intervention; coronavirus disease; drug market; efficacy trial; falls; follow-up; health literacy; high risk; improved; member; overdose prevention; pandemic preparedness; parent grant; peer; pre-exposure prophylaxis; programs; prospective; rapid testing; sex; substance abuse treatment; theories; uptake; vaccine acceptance; vaccine access; vaccine evaluation; vaccine hesitancy; vaccine-induced immunity

This competitive revision aims to increase access and uptake of COVID-19 testing and vaccination among people who inject drugs (PWID), a population highly vulnerable to COVID-19. The proposed RADxUP project, LinkUP, will be nested within the San Diego component of our parent grant, La Frontera, which was funded by NIDA in 04/20. To date, 31% of La Frontera PWID have tested SARS- CoV-2 antibody+, of whom 65% had not previously been tested for COVID-19. Only 3% had been vaccinated by 05/2021 and 45% were vaccine hesitant. Our specific aims are: AIM 1. To prospectively evaluate the prevalence, predictors and barriers to COVID-19 testing among PWID. AIM 2. To prospectively assess incidence, predictors and barriers to COVID-19 vaccination among PWID. AIM 3. To adapt and pilot an intervention offered at a mobile syringe services program (SSP) to improve uptake of COVID-19 testing and vaccination among PWID. AIM 4. To compare COVID testing and vaccination rates before and after the state introduces a) COVID-19 rapid testing and b) COVID-19 vaccination at the SSP, which represents a natural experiment. AIM 5. To prospectively assess the impact of COVID-19 testing and vaccination on PWIDs’ behaviors. To meet Aim 1 and 2, we will conduct interviews with 400 PWID in La Frontera, results which will be available in Fall 2021. Based on these findings and input from our Community and Scientific Advisory Board (CSAB), we will select and adapt a brief intervention to improve COVID-19 testing and vaccination uptake among PWID at the mobile van of our community partner, OnPoint. The LinkUP intervention will then be piloted among a subgroup of 150 La Frontera PWID who have not received COVID-19 vaccine or testing and will be implemented by OnPoint peer counsellors, who will also offer on-site rapid COVID-19 antigen testing and confirmatory PCR and referrals to the closest COVID-19 vaccination center (until vaccine is offered at OnPoint by the state). We will evaluate COVID-19 vaccine uptake independently through ongoing La Frontera study visits that will include self-reported interview data, linkage of electronic health records with the San Diego County COVID-19 database, and by analyzing SARSCoV-2 antibody patterns to differentiate between natural infection and vaccine-induced immunity. Results will be used to estimate effect sizes for a future efficacy trial and shared with the RADxUP consortium, policymakers and program planners. Since there are 185 SSPs across the country, our study will inform efforts to enable SSPs to become important ‘touchpoints’ to reach marginalized PWID, strengthening the nation’s pandemic preparedness infrastructure to reduce COVID-19 health disparities.

这一竞争性修订旨在增加COVID-19检测和疫苗接种的可及性和接受度